PerkinElmer to Host Newborn Screening Virtual Summit
24-hour live event will feature more than 40 sessions exploring the latest scientific advances in the field of newborn screening
WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, will host a Newborn Screening Virtual Summit to share the latest scientific advances in the field of newborn screening with a global audience of laboratory personnel, clinicians, researchers, regulators and parents. The 24-hour event will feature more than 40 presentations and live Q&A sessions presented in five languages by international experts and thought leaders in the field. The Summit is free of charge to attend, and registrants will have access to all recorded sessions through the month of December.
WHEN: Tuesday, December 8, 2020
WHERE: This event is virtual. Register to attend at the link here.
WHY: PerkinElmer is the global market leader in neonatal screening, currently serving customers in more than 100 countries. The Company has organized the Newborn Screening Virtual Summit to inform and educate individuals across the globe of the latest scientific advances in this field, including new and novel solutions for screening of various disorders, laboratory and workflow improvements and more.
Over the course of the 24-hour live stream, 40-plus sessions will be offered in one of five languages. There are country-specific sessions for attendees in China, Japan, Brazil, France and across Africa. Other sessions will focus on Duchenne Muscular Dystrophy, molecular advances in newborn screening such as SMA and SCID detection, as well how COVID-19 has impacted newborn screening programs. The keynote address is scheduled for 9:00 a.m. ET and will be delivered by Professor Moshe Hod, chair of the Pregnancy & Non Communicable Diseases Committee for the International Federation of Obstetrics and Gynecology (FIGO) and professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel-Aviv University, Israel.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com
# # #